Skip to main content
Top
Published in: Journal of Genetic Counseling 2/2014

01-04-2014 | Original Research

Disclosure Pattern and Follow-Up After the Molecular Diagnosis of BRCA/CHEK2 Mutations

Authors: D. Kegelaers, W. Merckx, P. Odeurs, J. van den Ende, B. Blaumeiser

Published in: Journal of Genetic Counseling | Issue 2/2014

Login to get access

Abstract

Five to 10 % of all breast cancer cases are due to mutations of high penetrance susceptibility genes, especially BRCA1 and BRCA2. In families with known BRCA mutations, disclosure of genetic test results could induce relatives to undergo genetic testing themselves and adopt cancer risk management strategies, if necessary. This study examines disclosure patterns of individuals tested for mutations in the BRCA1, BRCA2 and CHEK2 genes to first-degree relatives with emphasis on a possible gender difference. It also assesses which management strategy is preferred by mutation-positive women in Belgium and the influence of psychological characteristics on communication and choice of management strategy. Ninety-nine adults from BRCA/CHEK2 families, selected from the Centre of Medical Genetics of Antwerp, were included in the study. They were provided with medical and psychological questionnaires, the latter being the Self-Assessment Questionnaire, which is the Dutch version of the Spielberger State-Trait Anxiety Inventory and the Dutch version of the Coping Inventory for Stressful Situations (CISS-NL). The survey focused on disclosure, coping and management strategies with special attention on possible gender differences. The influence of socio-demographic and medical data on disclosure and cancer risk management as well as the influence of psychological features were examined by means of various statistical analyses. Ninety-nine patients were included, of whom 25 (25 %) were male. Eighty-seven percent of the participants informed all of their adult first-degree relatives about their mutation status without any gender discrimination. Seventy-eight percent of highly-educated participants informed all of their adult first-degree relatives, compared to 98 % of less formally-educated participants (p = 0.006). The majority of mutation-positive women preferred prophylactic surgery to surveillance. Psychological differences appeared to have little influence on disclosure patterns and management strategies. The gender difference seems to be less pronounced than previously assumed. A striking observation, however, is the fact that significantly more participants who were less formally-educated informed all of their adult first-degree relatives, compared to participants who were highly-educated. In our study population, most female mutation carriers opted for prophylactic surgery. Since the study population is small, further studies are needed to enhance the generalizability of these results.
Literature
go back to reference Anglian Breast Cancer Study Group. (2000). Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. British Journal of Cancer, 83(10), 1301–1308.PubMedCentralCrossRef Anglian Breast Cancer Study Group. (2000). Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. British Journal of Cancer, 83(10), 1301–1308.PubMedCentralCrossRef
go back to reference CHEK2 Breast Cancer Case–Control Consortium. (2004). CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. American Journal of Human Genetics, 74(6), 1175–1182.CrossRef CHEK2 Breast Cancer Case–Control Consortium. (2004). CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. American Journal of Human Genetics, 74(6), 1175–1182.CrossRef
go back to reference de Ridder, D. T. D., & van Heck, G. L. (1999). Coping Inventory for Stressful Situations: Handleiding (p. 15, 25, 26). Amsterdam: Pearson. de Ridder, D. T. D., & van Heck, G. L. (1999). Coping Inventory for Stressful Situations: Handleiding (p. 15, 25, 26). Amsterdam: Pearson.
go back to reference Endler, N. S., & Parker, J. D. A. (1990). Coping Inventory for Stressful Situations (CISS): Manual. Toronto: Multi-Health Systems. Endler, N. S., & Parker, J. D. A. (1990). Coping Inventory for Stressful Situations (CISS): Manual. Toronto: Multi-Health Systems.
go back to reference Finlay, E., Stopfer, J. E., Burlingame, E., Goldfeder Evans, K., Nathanson, K. L., Weber, B. L., et al. (2008). Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations. Genetic Testing, 12, 81–92.PubMedCentralPubMedCrossRef Finlay, E., Stopfer, J. E., Burlingame, E., Goldfeder Evans, K., Nathanson, K. L., Weber, B. L., et al. (2008). Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations. Genetic Testing, 12, 81–92.PubMedCentralPubMedCrossRef
go back to reference Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., et al. (1998). Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. American Journal of Human Genetics, 62(3), 676–689.PubMedCentralPubMedCrossRef Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., et al. (1998). Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. American Journal of Human Genetics, 62(3), 676–689.PubMedCentralPubMedCrossRef
go back to reference Hartmann, L. C., Sellers, T. A., Schaid, D. J., Frank, T. S., Soderberg, C. L., Sitta, D. L., et al. (2001). Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. Journal of the National Cancer Institute, 93, 1633–1637.PubMedCrossRef Hartmann, L. C., Sellers, T. A., Schaid, D. J., Frank, T. S., Soderberg, C. L., Sitta, D. L., et al. (2001). Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. Journal of the National Cancer Institute, 93, 1633–1637.PubMedCrossRef
go back to reference Hogg, R., & Friedlander, M. (2004). Biology of epithelial ovarian cancer: implications for screening women at high genetic risk. Journal of Clinical Oncology, 22, 1315–1327.PubMedCrossRef Hogg, R., & Friedlander, M. (2004). Biology of epithelial ovarian cancer: implications for screening women at high genetic risk. Journal of Clinical Oncology, 22, 1315–1327.PubMedCrossRef
go back to reference Kauff, N. D., Satagopan, J. M., Robson, M. E., Scheuer, L., Hensley, M., Hudis, C. A., et al. (2002). Risk reducing salpingo-oophorectomy in women with a BRCA1or BRCA2 mutation. New England Journal of Medicine, 346, 1609–1615.PubMedCrossRef Kauff, N. D., Satagopan, J. M., Robson, M. E., Scheuer, L., Hensley, M., Hudis, C. A., et al. (2002). Risk reducing salpingo-oophorectomy in women with a BRCA1or BRCA2 mutation. New England Journal of Medicine, 346, 1609–1615.PubMedCrossRef
go back to reference King, M. C., Wieand, S., Hale, K., Lee, M., Walsh, T., Owens, K., et al. (2001). Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2. National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. JAMA, 286, 2251–2256.PubMedCrossRef King, M. C., Wieand, S., Hale, K., Lee, M., Walsh, T., Owens, K., et al. (2001). Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2. National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. JAMA, 286, 2251–2256.PubMedCrossRef
go back to reference MacDonald, D. J., Sarna, L., van Servellen, G., Bastani, R., Giger Newman, J., & Weitzel, J. N. (2007). Selection of family members for communication of cancer risk and barriers to this communication before and after genetic cancer risk assessment. Genetics in Medicine, 9, 275–282.PubMedCrossRef MacDonald, D. J., Sarna, L., van Servellen, G., Bastani, R., Giger Newman, J., & Weitzel, J. N. (2007). Selection of family members for communication of cancer risk and barriers to this communication before and after genetic cancer risk assessment. Genetics in Medicine, 9, 275–282.PubMedCrossRef
go back to reference McKinnon, W., Naud, S., Ashikaga, T., Colletti, R., & Wood, M. (2007). Results of an intervention for individuals and families with BRCA mutations: a model for providing medical updates and psychosocial support following genetic testing. Journal of Genetic Counseling, 16, 433–456.PubMedCrossRef McKinnon, W., Naud, S., Ashikaga, T., Colletti, R., & Wood, M. (2007). Results of an intervention for individuals and families with BRCA mutations: a model for providing medical updates and psychosocial support following genetic testing. Journal of Genetic Counseling, 16, 433–456.PubMedCrossRef
go back to reference Nelson, H. D., Huffman, L. H., Fu, R., & Harris, E. L. (2005). Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the US preventive services task force. Annals of Internal Medicine, 143, 362–379.PubMedCrossRef Nelson, H. D., Huffman, L. H., Fu, R., & Harris, E. L. (2005). Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the US preventive services task force. Annals of Internal Medicine, 143, 362–379.PubMedCrossRef
go back to reference Patenaude, A. F., Dorval, M., DiGianni, L. S., Schneider, K. A., Chittenden, A., & Garber, J. E. (2006). Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. Journal of Clinical Oncology, 24, 700–706.PubMedCrossRef Patenaude, A. F., Dorval, M., DiGianni, L. S., Schneider, K. A., Chittenden, A., & Garber, J. E. (2006). Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. Journal of Clinical Oncology, 24, 700–706.PubMedCrossRef
go back to reference Phillips, K. A., Jenkins, M. A., Lindeman, G. J., McLachlan, S. A., McKinley, J. M., Weideman, P. C., et al. (2006). Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Clinical Genetics, 70, 198–206.PubMedCrossRef Phillips, K. A., Jenkins, M. A., Lindeman, G. J., McLachlan, S. A., McKinley, J. M., Weideman, P. C., et al. (2006). Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Clinical Genetics, 70, 198–206.PubMedCrossRef
go back to reference Spielberger, C. D., Gorsuch, R. L., Lushene, R., Vagg, P. R., & Jacobs, G. A. (1983). Manual for the State-Trait Anxiety Inventory. Palo Alto: Consulting Psychologists Press. Spielberger, C. D., Gorsuch, R. L., Lushene, R., Vagg, P. R., & Jacobs, G. A. (1983). Manual for the State-Trait Anxiety Inventory. Palo Alto: Consulting Psychologists Press.
go back to reference van der Ploeg, H. M. (2000). Handleiding bij de Zelf-Beoordelings Vragenlijst. 2e ed (p. 5, 6, 27). Amsterdam: Pearson. van der Ploeg, H. M. (2000). Handleiding bij de Zelf-Beoordelings Vragenlijst. 2e ed (p. 5, 6, 27). Amsterdam: Pearson.
go back to reference van Dijk, S., van Roosmalen, M. S., Otten, W., & Stalmeier, P. F. M. (2008). Decision making regarding prophylactic mastectomy: stability of preferences and the impact of anticipated feelings of regret. Journal of Clinical Oncology, 26, 2358–2363.PubMedCrossRef van Dijk, S., van Roosmalen, M. S., Otten, W., & Stalmeier, P. F. M. (2008). Decision making regarding prophylactic mastectomy: stability of preferences and the impact of anticipated feelings of regret. Journal of Clinical Oncology, 26, 2358–2363.PubMedCrossRef
go back to reference Wagner Costalas, J., Itzen, M., Malick, J., et al. (2003). Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program’s experience. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 119, 11–18.CrossRef Wagner Costalas, J., Itzen, M., Malick, J., et al. (2003). Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program’s experience. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 119, 11–18.CrossRef
go back to reference Warner, E., Plewes, D. B., Hill, K. A., Causer, P. A., Zubovits, J. T., Jong, R. A., et al. (2004). Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography and clinical breast examination. JAMA, 292, 1317–1325.PubMedCrossRef Warner, E., Plewes, D. B., Hill, K. A., Causer, P. A., Zubovits, J. T., Jong, R. A., et al. (2004). Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography and clinical breast examination. JAMA, 292, 1317–1325.PubMedCrossRef
Metadata
Title
Disclosure Pattern and Follow-Up After the Molecular Diagnosis of BRCA/CHEK2 Mutations
Authors
D. Kegelaers
W. Merckx
P. Odeurs
J. van den Ende
B. Blaumeiser
Publication date
01-04-2014
Publisher
Springer US
Published in
Journal of Genetic Counseling / Issue 2/2014
Print ISSN: 1059-7700
Electronic ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-013-9656-5

Other articles of this Issue 2/2014

Journal of Genetic Counseling 2/2014 Go to the issue